

(Sharecast News) - Oxford Biomedica said on Wednesday that the deadline for EQT to make a formal takeover bid has been extended amid ongoing prelimina...


(Alliance News) - Oxford BioMedica PLC on Wednesday said it has signed a new commercial supply deal with Bristol-Myers Squibb Co.


(Sharecast News) - Gene and cell therapy company Oxford Biomedica said on Wednesday that it has expanded its strategic partnership with Bristol Myers ...


FTSE 100 up 0.56%, FTSE 250 up 1.4% *


Oxford BioMedica PLC - Oxford, England-based gene and cell therapy developer - Says it notes recent press speculation and that it has received an unso...


(Sharecast News) - Oxford Biomedica confirmed on Wednesday that it has received unsolicited takeover approaches from private equity firm EQT.


(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and on Thursday:


(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: